Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 17 pseudogene 4 (KRT17P4) is a noncoding pseudogene related to the functional keratin 17 gene (KRT17), a member of the type I intermediate filament protein family that is important for epithelial structure and homeostasis. Unlike KRT17, mutations or expression changes in KRT17P4 are not known to have biological or therapeutic significance. Pseudogenes like KRT17P4 do not produce functional proteins and thus are not pursued as therapeutic targets or used as biomarkers. For information about disease mechanisms, drug interactions, or biological function, the active gene KRT17—not KRT17P4—is relevant. Additional note: If the intended target was the functional protein keratin 17 (KRT17), please refer to it by its correct canonical name "Keratin 17" and abbreviation "KRT17." Otherwise, information about KRT17P4 as a target or receptor is not applicable, as it is not a protein-coding gene[5][1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 17 pseudogene 4 (KRT17P4).